Back
Niche senior pharma licensing reduces applicants but strong brand and metro location increase competition.
Requires pharma/biotech licensing, clinical interpretation, and specialized deal experience, limiting cross-industry transferability.
Explicit 10–12 years, domain-specific licensing expertise, and cross-border deal experience create strict hiring filters.
Login to See Your Match Score
Create a free account or log in to unlock your CV match score across:
Lead sourcing and relationship management for global innovation licensing opportunities in biotech and pharma, focusing on oncology and specialty therapies.
Own end-to-end due diligence and evaluation of assets across clinical, scientific, and commercial aspects with cross-functional teamwork.
Drive deal structuring, valuation, negotiations, and portfolio strategy contribution, managing complex multi-asset transactions and aligning senior leadership.
10-12 years in business development, licensing, or consulting within pharma or biotech relevant to innovation-focused asset evaluation and deal execution.
Advanced degree preferred (PhD / PharmD / MD / MBA) with ability to interpret clinical data into commercial value.
Experience in cross-border transactions involving US, Europe, or China markets.
Not explicitly mentioned in the JD: Notice period requirement.
Proven capability to independently lead complex deals from origination through negotiation, coordinating cross-functional teams.
Experience handling oncology or specialty portfolios with strategic and commercial asset evaluation focus.
Comfortable operating autonomously in ambiguous environments with strong executive communication and stakeholder management.